BG
GNMK

Bellevue Group’s GenMark Diagnostics, Inc GNMK Stock Holding History

Bellevue Group’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,606,636
Closed -$38.1M – 235
2020
Q4 		$38.1M Buy
2,606,636
+1,342,825
+106% +$17.8M 0.44% 66
2020
Q3 		$17.9M Sell
1,263,811
-225,473
-15% -$3.45M 0.25% 95
2020
Q2 		$21.9M Sell
1,489,284
-922,642
-38% -$9.37M 0.31% 76
2020
Q1 		$9.94M Sell
2,411,926
-29,315
-1% -$137K 0.19% 89
2019
Q4 		$11.7M Buy
2,441,241
+173,989
+8% +$960K 0.19% 85
2019
Q3 		$13.7M Sell
2,267,252
-85,815
-4% -$536K 0.26% 73
2019
Q2 		$15.3M Hold
2,353,067
– – 0.26% 67
2019
Q1 		$16.7M Buy
2,353,067
+353,527
+18% +$2.33M 0.92% 35
2018
Q4 		$9.72M Buy
1,999,540
+660,038
+49% +$3.44M 0.64% 45
2018
Q3 		$9.85M Buy
1,339,502
+153,000
+13% +$1.12M 0.62% 51
2018
Q2 		$7.57M Hold
1,186,502
– – 0.65% 50
2018
Q1 		$6.46M Buy
1,186,502
+412,825
+53% +$2.05M 0.64% 52
2017
Q4 		$3.23M Buy
773,677
+250,000
+48% +$1.5M 0.34% 63
2017
Q3 		$5.04M Buy
523,677
+118,499
+29% +$1.23M 0.53% 53
2017
Q2 		$4.79M Buy
405,178
+92,512
+30% +$1.18M 0.57% 59
2017
Q1 		$4.01M Buy
+312,666
New +$3.76M 0.53% 54

Other funds holding GNMK

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bellevue Group's GNMK Position: Q1 2021 in Review

Bellevue Group sold out of GenMark Diagnostics, Inc (GNMK) in Q1 2021, closing a stake of 2,606,636 shares — an estimated $38.1M sold.

Bellevue Group first reported a position in GNMK in Q1 2017 and held it in 16 quarters. The position peaked at $38.1M in Q4 2020. 164 funds tracked by Wall St. Rank hold GNMK as of Q1 2021.

  • Bellevue Group reported no remaining GenMark Diagnostics, Inc position as of Q1 2021 after selling out during the quarter.
  • Bellevue Group sold 2,606,636 GenMark Diagnostics, Inc shares in Q1 2021, an estimated $38.1M.
  • Bellevue Group first reported a position in GenMark Diagnostics, Inc in Q1 2017 and held it in 16 quarters.
  • Bellevue Group's GenMark Diagnostics, Inc position peaked at $38.1M in Q4 2020.
  • 164 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q1 2021.

Based on Bellevue Group's 13F filing for Q1 2021, filed 12 May 2021.